Outlook Therapeutics (OTLK) EBT Growth (1y) (2016 - 2026)
Outlook Therapeutics (OTLK) EBT Growth (1y) (2016 - 2026) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
EBT Growth (1y) (Qtr) |
| 1 |
Alterity Therapeutics |
814,307.08 Bn |
814,307.05 Bn |
- |
- |
| 2 |
Belite Bio |
55,320.00 Bn |
55,320.00 Bn |
- |
-88.68% |
| 3 |
Quantum Biopharma |
17,149.72 Bn |
17,149.72 Bn |
- |
13.34% |
| 4 |
Legend Biotech |
3,590.00 Bn |
3,589.71 Bn |
242.10 Mn |
-51.60% |
| 5 |
Akari Therapeutics |
1,650.72 Bn |
1,650.72 Bn |
- |
-313.33% |
| 6 |
Evaxion A |
1,522.09 Bn |
1,522.07 Bn |
- |
-79.57% |
| 7 |
Psyence Biomedical |
229.39 Bn |
229.38 Bn |
- |
-230.18% |
| 8 |
Vertex Pharmaceuticals |
113.09 Bn |
105.85 Bn |
2.59 Bn |
71.54% |
| 9 |
Abivax |
90.15 Bn |
90.15 Bn |
- |
- |
| 10 |
Outlook Therapeutics |
86.15 Mn |
78.40 Mn |
-21,888.00 |
90.39% |
| Date | Value |
|---|
| Mar 31, 2026 |
90.39% |
| Dec 31, 2025 |
37.59% |
| Sep 30, 2025 |
-360.88% |
| Jun 30, 2025 |
-145.38% |
| Mar 31, 2025 |
59.44% |
| Dec 31, 2024 |
-109.31% |
| Sep 30, 2024 |
143.81% |
| Jun 30, 2024 |
314.80% |
| Mar 31, 2024 |
-1,618.20% |
| Dec 31, 2023 |
34.20% |
| Sep 30, 2023 |
9.44% |
| Jun 30, 2023 |
-17.87% |
| Mar 31, 2023 |
66.24% |
| Dec 31, 2022 |
-19.30% |
| Sep 30, 2022 |
-7.01% |
| Jun 30, 2022 |
-43.81% |
| Mar 31, 2022 |
-50.35% |
| Dec 31, 2021 |
8.37% |
| Sep 30, 2021 |
-35.09% |
| Jun 30, 2021 |
-94.03% |
